Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000649467 | SCV000771295 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001354634 | SCV002009962 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386098 | SCV002702214 | benign | Hereditary cancer-predisposing syndrome | 2015-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Department of Pathology and Laboratory Medicine, |
RCV001354634 | SCV001549298 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The SDHA p.Ser408Leu variant was not identified in the literature or in the Cosmic database but was identified in dbSNP (ID: rs76896145), ClinVar (reported as benign by Invitae for mitochondrial complex II deficiency and paragangliomas 5) and LOVD 3.0. The variant was identified in control databases in 21 of 273542 chromosomes at a frequency of 0.000077 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 4 of 24354 chromosomes (freq: 0.000164), European (non-Finnish) in 16 of 123988 chromosomes (freq: 0.000129) and South Asian in 1 of 28962 chromosomes (freq: 0.000035); it was not observed in the Latino, Ashkenazi Jewish, East Asian, European (Finnish), and Other populations. The p.Ser408 residue is conserved in mammals but not in more distantly related organisms, and four out of five computational analyses (PolyPhen-2, SIFT, BLOSUM, and MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |